Navigation Links
The GADA Group Ltd. ("GADA") Welcomes its new Shareholder, RBS Equity Finance ("RBEF")

LONDON, July 1, 2011 /PRNewswire/ --


GADA, one of the leading European healthcare distributors and providers of specialized services for public and private hospital facilities in Italy, Romania and Turkey, is proud to announce an investment by new shareholder RBEF.

GADA supplies a broad range of integrated services to public and private healthcare facilities, including the distribution of high-tech medical devices and disposables, clinical and maintenance services, and was incorporated in Italy in the late 1970s. Today the company is a unique and easily scalable platform, with multi-regional distribution from 2009, following the acquisition of a leading Romanian distributor and entry into Turkey.

During the past 5 years, GADA has doubled its revenues and consistently strengthened its balance sheet. In particular, an intensive consolidation project has been commenced, positioning GADA for the next stage of its pan-European expansion plan.

RBEF is investing significant equity to support GADA's expansion in existing operating countries and to finance further acquisitions across Central and Eastern Europe. RBEF's funding and significant experience will support continuing improvements to the existing offering and accelerate growth through further selective acquisitions.

Sante Giovanni Albonetti, CEO of the GADA Group, said of the investment: "GADA has achieved a number of important milestones during the past decade and this success is paying off, as evidenced by the arrival of an important institutional partner. We are very enthusiastic about the entry of RBEF into the shareholder group and look forward to working together to deliver the next phase of our expansion plan. This investment marks an excellent result for the company and will greatly benefit our current and future associates, suppliers and customers."

Andrew Lawley, Managing Director of RBS Equity Finance, added: "Gada is a leading European medical technology distributor with an exceptional range of opportunities to pursue. We are extremely pleased to have made this investment and look forward to actively support the company in delivering its organic and acquisition plans."

About The GADA Group:

GADA is a leading pan-European supplier of integrated services to public and private healthcare facilities in Italy, Romania and Turkey. Its headquarters are located in London, UK.

About RBS Equity Finance:

RBS Equity Finance manages the RBS Special Opportunities Fund, a £1.1bn fund with a broad investment mandate, covering everything from majority equity investment through to mezzanine debt. This makes them an excellent partner for high quality, growth-focused businesses, as well as a provider of M&A expertise and capital in acquisition-led growth scenarios. RBS Special Opportunities Fund currently backs over 20 companies across a variety of sectors and has a strong track record in a range of sectors.


For further information, please contact:

The GADA Group

Daniel J. Novacek, Tel: +44-7912-514-029

For media enquiries call Alex Simmons, Smithfield, +44-20-7360-4900

RBS Equity Finance

Andrew Lawley, Tel +44-20-7085-8364

SOURCE The Gada Group
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. OM Group Announces Retirement Plans of Chief Financial Officer Kenneth Haber
2. MiMedx Group Receives FDA Clearance to Market Its HydroFix™ Ortho Shield™ Device
3. Foundation Venture Capital Group Invests in Company Developing Plaque-Reducing Dental Hygiene Products
4. ANF Group, Inc. Completes New Joe DiMaggio Childrens Hospital
5. Unity Management Group, MCC Announce Increased Contracts and Major Installations at US and South American Pharmaceutical Companies
6. Nolan Law Group: Jury Finds Against Baxter Healthcare In Nations First Contaminated Chinese Heparin Case
7. Assured Pharmacy Engages The Investor Relations Group
8. Caliper Owners Group Meeting Showcases Transformative Technologies for Advancing Personalized Medicine
9. Simcere Pharmaceutical Group Provides Notice of Annual General Meeting
10. Lilly and Investor Group Form New Critical Care Company BioCritica, Sign Xigris License Agreement
11. HealthPartners and The Chartis Group Collaborate to Improve Health Care Quality, Service, and Cost
Post Your Comments:
(Date:6/26/2016)... , June 26, 2016 One of Australia,s ... announced the formation of a new biotechnology company, Noxopharm Limited [ABN ... in an IPO and to list on the ASX. ... NOX66, ready to enter a Phase 1 clinical study later this ... to address one of the biggest problems facing cancer patients - ...
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals plc ... period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, ... of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ... (Eastern Daylight Time). As previously announced on ... a definitive merger agreement under which Jazz Pharmaceuticals has ...
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... ... recently awarded their highest five-star rating to Best Buy Eyeglasses, an ... United States and Canada wear eyeglasses. Once considered to be a purely functional part ... fashion statement. Even celebrities use glasses as a way of creating an iconic image—like ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his ... David Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps ... in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to ...
(Date:6/24/2016)... ... ... A recent article published June 14 on E Online details ... to state that individuals are now more comfortable seeking to undergo not only the ... and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) notes ...
Breaking Medicine News(10 mins):